Publication Name	World Journal of Diabetes
Manuscript ID	13424
Country	Japan

Received	2014-08-22 17:42
Peer-Review Started	2014-08-23 10:05
To Make the First Decision	2014-09-28 13:44
Return for Revision	2014-10-05 18:04
Revised	2014-10-17 12:29
Second Decision	2015-03-20 11:51
Accepted by Journal Editor-in-Chief	2015-03-20 17:19
Accepted by Executive Editor-in-Chief	2015-04-07 15:45
Articles in Press	2015-04-07 15:45
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2015-06-06 11:04
Publish the Manuscript Online	2015-06-20 17:24

ISSN	1948-9358 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Urology & Nephrology
Manuscript Type	Review
Article Title	Diabetes therapies in hemodialysis patients: Dipeptidase-4 inhibitors
Manuscript Source	Invited Manuscript
All Author List	Yuya Nakamura, Hitomi Hasegawa, Mayumi Tsuji, Yuko Udaka, Masatomo Mihara, Tatsuo Shimizu, Michiyasu Inoue, Yoshikazu Goto, Hiromichi Gotoh, Masahiro Inagaki and Katsuji Oguchi
Funding Agency and Grant Number
Corresponding Author	Yuya Nakamura, MD, Saiyu Soka Hospital, 1-21-37, Kitaya, Soka-city Saitama-ken 340-0046, Japan. y.nakamura@med.showa-u.ac.jp
Key Words	Dipeptidase-4 inhibitors; Hemodialysis; Diabetes mellitus; Blood glucose-related factors; Anti-inflammatory effects
Core Tip	Until now, the effectiveness of dipeptidase-4 (DPP-4) inhibitors on diabetic hemodialysis (HD) patients has not been reviewed. All 7 DPP-4 inhibitors are available for HD patients; administration is once daily with dose adjustments. The effectiveness of DPP-4 inhibitor treatment in HD patients is high, and adverse events do not increase as a result. DPP-4 inhibitors may prevent inflammation and atherosclerosis, which are principal prognostic factors for HD patients. In summary, DPP-4 inhibitors are key drugs in new treatment strategies for HD patients with diabetes and limited choices for its treatment.
Publish Date	2015-06-20 17:24
Citation	Nakamura Y, Hasegawa H, Tsuji M, Udaka Y, Mihara M, Shimizu T, Inoue M, Goto Y, Gotoh H, Inagaki M, Oguchi K. Diabetes therapies in hemodialysis patients: Dipeptidase-4 inhibitors. World J Diabetes 2015; 6(6): 840-849
URL	http://www.wjgnet.com/1948-9358/full/v6/i6/840.htm
DOI	http://dx.doi.org/10.4239/wjd.v6.i6.840

Full Article (PDF)	WJD-6-840.pdf
Full Article (Word)	WJD-6-840.doc
Manuscript File	13424-Review.docx
Answering Reviewers	13424-Answering reviewers.pdf
Conflict-of-Interest Disclosure Form	13424-Conflict-of-interest statement.pdf
Copyright License Agreement	13424-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate	13424-Language certificate.pdf
Peer-review Report	13424-Peer-review(s).pdf
Journal Editor-in-Chief Review Report	13424-Journal editor-in-chief review report.pdf
Scientific Misconduct Check	13424-Scientific misconduct check.pdf
Scientific Editor Work List	13424-Scientific editor work list.pdf